3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
24
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Mantle-Cell
66
Lymphoma
65
Lymphoma, Non-Hodgkin
43
Lymphoma, Follicular
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Lymphoma, Large B-Cell, Diffuse
34
Waldenstrom Macroglobulinemia
33
Lymphoma, B-Cell, Marginal Zone
30
Leukemia, Lymphocytic, Chronic, B-Cell
28
Recurrence
18
Multiple Myeloma
17
Hodgkin Disease
17
Lymphoma, B-Cell
14
Leukemia, Myeloid, Acute
14
Burkitt Lymphoma
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Large-Cell, Anaplastic
13
Leukemia
12
Immunoblastic Lymphadenopathy
12
Mycosis Fungoides
11
Lymphoma, T-Cell, Cutaneous
11
Lymphoma, Large-Cell, Immunoblastic
11
Sezary Syndrome
10
Lymphoma, T-Cell, Peripheral
10
Neoplasms, Plasma Cell
9
Neoplasms
9
Lymphoma, T-Cell
8
Myelodysplastic Syndromes
7
Lymphoma, Extranodal NK-T-Cell
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Interventions
Peripheral Blood Stem Cell Transplantation
10
Cyclophosphamide
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Radiotherapy
4
Filgrastim
4
Carboplatin
4
Busulfan
4
Tacrolimus
3
Melphalan
3
Etoposide
3
Epoetin Alfa
3
Darbepoetin alfa
3
sargramostim
2
liposomal amphotericin B
2
Thiotepa
2
Therapeutics
2
Morphine
2
Methylprednisolone
2
Interferon-alpha
2
Fentanyl
2
Early Intervention, Educational
2
Caspofungin
2
Carmustine
2
Antilymphocyte Serum
2
pyroxamide
1
nelarabine
1
ferrous sulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Bortezomib
×
Lymphoid
×
Clear all
NCT00006362
2011-08-03
PS-341 in Treating Patients With Advanced Cancer
Mayo Clinic
Phase 1
Completed